Neurotrauma Reports

metrics 2024

Unveiling insights that drive neurotrauma innovation.

Introduction

Neurotrauma Reports, published by MARY ANN LIEBERT, INC, stands at the forefront of disseminating pivotal research within the evolving field of neuroscience. With an emphasis on both cellular and molecular neuroscience and developmental neuroscience, this open access journal, initiated in 2020, aims to bridge gaps in knowledge concerning neurotrauma, a critical area impacting brain health and recovery. Although currently positioned in the lower quartiles as per the 2023 category rankings, the journal provides invaluable insights that foster academic dialogue and collaboration among researchers, professionals, and students alike. Through its commitment to open access, Neurotrauma Reports ensures that cutting-edge research is accessible to a diverse audience, enhancing the visibility of emerging studies and fostering innovation within the field. Readers can explore this journal to stay updated with the latest findings, methodologies, and reviews that are shaping our understanding of neurotrauma, ultimately contributing to improved treatments and outcomes.

Metrics 2024

SCIMAGO Journal Rank-
Journal Impact Factor1.80
Journal Impact Factor (5 years)2.10
H-Index-
Journal IF Without Self1.80
Eigen Factor0.00
Normal Eigen Factor0.16
Influence0.62
Immediacy Index0.40
Cited Half Life2.40
Citing Half Life8.30
JCI0.47
Total Documents-
WOS Total Citations314
SCIMAGO Total Citations-
SCIMAGO SELF Citations-
Scopus Journal Rank-
Cites / Document (2 Years)-
Cites / Document (3 Years)-
Cites / Document (4 Years)-

Metrics History

Rank 2024

IF (Web Of Science)

CLINICAL NEUROLOGY
Rank 188/277
Percentile 32.30
Quartile Q3
NEUROSCIENCES
Rank 242/310
Percentile 22.10
Quartile Q4

JCI (Web Of Science)

CLINICAL NEUROLOGY
Rank 204/278
Percentile 26.62
Quartile Q3
NEUROSCIENCES
Rank 250/310
Percentile 19.35
Quartile Q4

Quartile History

Similar Journals

BRAIN RESEARCH

Fostering breakthroughs in developmental and molecular biology.
Publisher: ELSEVIERISSN: 0006-8993Frequency: 24 issues/year

BRAIN RESEARCH is a premier journal published by Elsevier, specializing in the intricate domains of neuroscience, developmental biology, and molecular biology. Established in 1966, this esteemed publication has become a cornerstone for researchers, professionals, and students dedicated to advancing our understanding of brain function and disorders. With an impressive impact factor and a consistent presence in the Q2 quartiles across key categories—such as Developmental Biology, Neurology, and Neuroscience—it stands out as an essential resource for disseminating innovative research and pioneering insights. The journal's scope encompasses both clinical and fundamental studies, fostering a multidisciplinary approach to the complexities of neural systems. Although it is not an open-access journal, BRAIN RESEARCH provides a vital platform for sharing progressive findings that can inspire future studies and contribute significantly to the evolutionary discourse in neuroscience. Based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, BRAIN RESEARCH continues to shape the landscape of neuroscience research, inviting submissions that explore the latest discoveries and therapeutic strategies.

NeuroSci

Fostering Innovation in the World of Neuroscience
Publisher: MDPIISSN: Frequency: 4 issues/year

NeuroSci is an esteemed open-access journal published by MDPI, dedicated to advancing the field of neuroscience through high-quality research dissemination. Operating under the E-ISSN 2673-4087, this journal aims to foster collaboration and innovation by providing a platform for original research articles, reviews, and theoretical studies that address the complexities of the brain and nervous system. NeuroSci encourages submissions from a wide array of disciplines including cognitive neuroscience, neurobiology, neurophysiology, and neuropsychology, making it an essential resource for researchers, professionals, and students alike. With its commitment to open accessibility, NeuroSci ensures that groundbreaking findings are readily available to the global community, thereby enhancing the impact and exchange of knowledge in neuroscience. The journal is located at ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, contributing to the reputation of MDPI as a leading publisher in the academic landscape.

NEUROMOLECULAR MEDICINE

Fostering Innovation in Cellular and Molecular Neuroscience
Publisher: HUMANA PRESS INCISSN: 1535-1084Frequency: 4 issues/year

NEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.

CLINICAL EEG AND NEUROSCIENCE

Unlocking the Mysteries of Neurological Disorders
Publisher: SAGE PUBLICATIONS INCISSN: 1550-0594Frequency: 6 issues/year

CLINICAL EEG AND NEUROSCIENCE, published by SAGE Publications Inc, stands as a pivotal journal in the fields of neurology and neuroscience, with a focus on the latest research and advancements in clinical electroencephalography and neurophysiology. Since its inception in 1970, the journal has provided a platform for rigorous scholarly work, offering valuable insights into neurological disorders and EEG technology. With its current categorization in the Q2 and Q3 quartiles across various subfields of medicine and neurology, it ranks prominently in the Scopus database, emphasizing its significance in academic discourse. The journal's commitment to disseminating high-quality research is underscored by its open access options, facilitating broader accessibility to its published findings. For researchers, clinicians, and students alike, CLINICAL EEG AND NEUROSCIENCE remains an essential resource for keeping abreast of the evolving landscape of neurological studies.

Brazilian Neurosurgery-Arquivos Brasileiros de Neurocirurgia

Innovating the Future of Neurosurgery
Publisher: GEORG THIEME VERLAG KGISSN: 0103-5355Frequency: 4 issues/year

Brazilian Neurosurgery-Arquivos Brasileiros de Neurocirurgia, published by GEORG THIEME VERLAG KG, is a distinguished peer-reviewed open access journal that has been making significant contributions to the field of neurosurgery since its transition to open access in 2015. This Brazilian journal, which is accessible to a global audience, aims to disseminate high-quality research articles, reviews, and case reports that enhance the understanding and practice of neurosurgery and clinical neurology. Despite its current ranking in the Q4 category for both neurology and surgery in 2023, the journal is committed to improving its impact and accessibility for researchers, medical professionals, and students worldwide. As an important platform for innovative ideas and discussions, it takes pride in publishing scientifically rigorous content that informs and shapes the future of neurosurgical practices. With the rise of open access publishing, Brazilian Neurosurgery aligns itself with contemporary trends, making vital research readily available to its diverse readership while nurturing academic collaborations within the neurosurgical community.

NEUROSURGERY

Pioneering Research for Enhanced Patient Care.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0148-396XFrequency: 12 issues/year

NEUROSURGERY, published by Lippincott Williams & Wilkins, stands as a foremost journal in the field of clinical neurology and surgery, reflecting a commitment to advancing knowledge and practice through high-quality research and discourse. With an impact factor indicative of its scholarly significance and a remarkable Scopus ranking placing it in the Q1 category for both neurology and surgery, this journal provides a vital platform for clinicians, researchers, and students to explore cutting-edge developments and innovations. NEUROSURGERY publishes peer-reviewed articles that span the spectrum of neurosurgical practice, from basic science discoveries to clinical applications, fostering a collaborative exchange of ideas and methodologies. Since its inception in 1977, the journal has maintained a focus on delivering substantive research that informs practice and enhances patient care, making it an essential resource for professionals dedicated to the fields of neurology and surgery. The journal is based in India, and while it currently does not offer open access options, its rich archive from 1977 to 2024 ensures a comprehensive repository of knowledge for those engaged in this critical area of medicine.

Brain Impairment

Bridging research and application in cognitive health.
Publisher: CAMBRIDGE UNIV PRESSISSN: 1443-9646Frequency: 3 issues/year

Brain Impairment, published by Cambridge University Press, is a pivotal academic journal dedicated to advancing the understanding of neurological conditions and cognitive processes. With its ISSN 1443-9646 and E-ISSN 1839-5252, this esteemed journal has been at the forefront of research in the fields of Behavioral Neuroscience, Cognitive Neuroscience, and Neuropsychology since its inception in 2004. Covering a broad scope, it addresses critical insights into brain function, impairments, and therapies, making it a valuable resource for researchers, clinicians, and students alike. Brain Impairment holds various rankings, including Q4 in Behavioral Neuroscience and Q2 in Speech and Hearing, reflecting its significance in the academic community. While the journal operates under print access, its rich content serves as an essential reference for professional development and scholarly discussion in the UK and beyond. Researchers and practitioners can rely on this journal to provide cutting-edge research and reviews that inform clinical practice and shape future studies in neurology and cognitive neuroscience.

Journal of Neurological Surgery Part A-Central European Neurosurgery

Exploring the frontiers of neurological surgery.
Publisher: THIEME MEDICAL PUBL INCISSN: 2193-6315Frequency: 6 issues/year

The Journal of Neurological Surgery Part A – Central European Neurosurgery is a prominent peer-reviewed publication dedicated to advancing the field of neurosurgery and its related disciplines. Published by THIEME MEDICAL PUBL INC and based in Germany, this journal has been a platform for critical advancements in clinical neurology and surgery since its inception in 2012, and it is set to continue through 2024. With a current impact factor reflecting its influence in the medical community, the journal ranks in the Q3 quartile across the categories of Medicine (miscellaneous), Neurology (clinical), and Surgery for 2023, ensuring a robust participation from the academic and medical professionals alike. It is indexed in Scopus, highlighting its global recognition, with rankings of #248/551 and #257/400 in the fields of Medicine & Surgery and Neurology, respectively. The journal features a range of open access options, thereby facilitating unrestricted dissemination of high-quality research to a wide audience. As a valuable resource, it aims to promote the exchange of innovative ideas and research findings that can contribute to clinical practice and improve patient outcomes in neurosurgery.

ACS Chemical Neuroscience

Unraveling the Molecular Mysteries of Neural Function.
Publisher: AMER CHEMICAL SOCISSN: 1948-7193Frequency: 12 issues/year

ACS Chemical Neuroscience, published by the American Chemical Society, is a premier journal dedicated to exploring the complex interactions between chemistry and neuroscience. With its ISSN 1948-7193 and a distinguished impact factor that positions it within the top quartiles across multiple categories, including Q1 in Biochemistry, Q2 in Cell Biology, and Q1 in Physiology, this journal serves as an essential platform for researchers engaged in cutting-edge studies from 2010 to 2024. Positioned within the top 15% of its field in Cognitive Neuroscience according to Scopus rankings, ACS Chemical Neuroscience strives to foster interdisciplinary collaboration, publishing significant advancements that integrate chemical concepts with neurological processes. Despite its traditional publication model, the journal is committed to maintaining rigorous peer-review standards and providing valuable insights that drive innovations in therapeutics and understanding the biochemical underpinnings of brain function. Researchers, professionals, and students alike will find in this journal a vital resource for the latest findings and methodologies in the dynamic intersection of chemistry and neuroscience.

Indian Journal of Neurotrauma

Enhancing accessibility to vital neurotrauma insights.
Publisher: GEORG THIEME VERLAG KGISSN: 0973-0508Frequency: 3 issues/year

Indian Journal of Neurotrauma is a premier Open Access journal published by GEORG THIEME VERLAG KG, dedicated to advancing the field of neurotrauma through rigorous research and comprehensive scholarly discourse. With an ISSN of 0973-0508 and E-ISSN 2213-3739, this journal provides a vital platform for researchers, clinicians, and students to share findings and insights on the multifaceted aspects of neurotrauma, including its clinical management, epidemiology, and innovative treatment approaches. Since adopting an Open Access model in 2020, the journal has enhanced its accessibility, ensuring that groundbreaking studies and critical reviews are available to a wider audience, thereby fostering collaboration and innovation. The Indian Journal of Neurotrauma aims to serve as a comprehensive resource for those involved in public health, neurology, and trauma care, making significant contributions to the understanding and treatment of neurotrauma globally.